Literature DB >> 26859089

Time for Personalized Biologic Therapy: One Size Does Not Fit All.

Anne M Griffiths1.   

Abstract

Mesh：

Year:  2016        PMID： 26859089     DOI： 10.1097/MPG.0000000000001149

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  1 in total

1.  Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.

Authors:  Wenhui Zhang; Astrid Scalori; Franklin Fuh; Jacqueline McBride; Gaohong She; Jaroslaw Kierkus; Bartosz Korczowksi; Regan Li; Mariam Abouhossein; Alysha Kadva; K T Park; Meina Tao Tang
Journal:  Inflamm Bowel Dis       Date:  2022-09-01       Impact factor: 7.290
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.